| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |